NCT05465408View on ClinicalTrials.gov

Culturally Aware AET Non-Initiation Intervention

NACompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

July 21, 2022

Primary Completion Date

November 20, 2024

Study Completion Date

November 20, 2024

Conditions
Breast CancerSurvivorshipTreatment ComplianceTreatment AdherenceTreatment Refusal
Interventions
BEHAVIORAL

Culturally Aware Adjuvant Endocrine Therapy (AET) Non-Initiation Intervention

One-to-One virtual (videoconference) behavioral intervention.

Trial Locations (11)

02114

Massachusetts General Hospital Cancer Center, Boston

02215

Dana-Farber Cancer Institute, Boston

02135

Dana-Farber Cancer Institute at St Elizabeth's Medical Center, Brighton

01742

Emerson Hospital/MGH Cancer Center, Concord

01923

Mass General at North Shore Cancer Center, Danvers

02035

Dana-Farber Brigham Cancer Center - Foxborough, Foxborough

01844

Dana-Farber Cancer Institute - Merrimack Valley, Methuen

01757

Dana-Farber Brigham Cancer Center at Milford Regional Medical Center, Milford

02462

Mass General at Newton Wellesley Hospital, Newton

02190

Dana-Farber Brigham Cancer Center with South Shore Hospital, Weymouth

03053

Dana-Farber/New Hampshire Onoclogy-Hematology, Londonderry

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER